Trinity Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Trinity Financial Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,710	Closed	-$215K	–	76
2023 Q3	$215K	Hold	3,710	–	–	0.11%	68
2023 Q2	$237K	Hold	3,710	–	–	0.13%	67
2023 Q1	$257K	Hold	3,710	–	–	0.16%	59
2022 Q4	$267K	Hold	3,710	–	–	0.18%	55
2022 Q3	$264K	Buy	+3,710	New	+$269K	0.19%	55
2022 Q2	–	Sell	-3,710	Closed	-$271K	–	28
2022 Q1	$271K	Sell	3,710 -100	-3%	-$6.71K	0.17%	55
2021 Q4	$238K	Sell	3,810 -500	-12%	-$29.3K	0.14%	54
2021 Q3	$255K	Hold	4,310	–	–	0.17%	42
2021 Q2	$288K	Sell	4,310 -21	-0.5%	-$1.37K	0.2%	41
2021 Q1	$273K	Buy	4,331 +1	+0%	+$62	0.21%	40
2020 Q4	$269K	Buy	+4,330	New	+$266K	0.24%	47

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Trinity Financial Advisors's BMY Position: Q4 2023 in Review

Trinity Financial Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 3,710 shares — an estimated $215K sold.

Trinity Financial Advisors first reported a position in BMY in Q4 2020 and held it in 11 quarters. The position peaked at $288K in Q2 2021. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Trinity Financial Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Trinity Financial Advisors sold 3,710 Bristol-Myers Squibb shares in Q4 2023, an estimated $215K.
Trinity Financial Advisors first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 11 quarters.
Trinity Financial Advisors's Bristol-Myers Squibb position peaked at $288K in Q2 2021.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Trinity Financial Advisors's 13F filing for Q4 2023, filed 6 Feb 2024.